Archive for June, 2012

Aesthetics Pharmaceutical Company Selects 360 Vantage Closed Loop…

Now solution gives the sales force the ability to present approved marketing materials directly to prescribers via the Apple iPad(PRWeb June 27, 2012)Read the full story at

BIT Companies and DRG Diagnostics Unveil First Hybrid Analyzer

BIT Companies and DRG Diagnostics GmbH have partnered to create the first hybrid analyzer – a fully-automated, random-access analyzer for immunoassays and clinical chemistry. This innovative and…(PRWeb June 27, 2012)Read the full story at http://w…

Oil 4 Less LLC, the Home of Codatron TM Announces New Management…

Oil 4 Less LLC the exclusive manufacturer of the replacement Victoreen Corotron – high voltage shunt regulator circuit has moved the Corporate Office to 7205A Martin Way E#121, Olympia WA, leaving the…(PRWeb June 27, 2012)Read the full story at ht…

New Bed Bug Bully Spray Promises Easy Bed Bug Treatment with Big… recently made available to the public its new Bed Bug Bully. The product, made of natural ingredients, promises an easy, affordable and safe bed bug treatment.(PRWeb June 27, 2012)Read the full story at…

Drug Patent Expirations for Jun 18 2012

If your reader cannot render the information below, go to to see the latest expirations

<TD align=right–>
Who are the leading pharmaceutical patent challengers? A report on
Paragraph IV challenges<!–/td>

newsletter is a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents

Simple flat-rate
database subscription plans

Premium Plan Basic Plan
One year $1,995 Subscribe $1,795 Subscribe $1,095 Subscribe
One month $525 Subscribe $425 Subscribe $325 Subscribe
48 hours $95 Subscribe $75 Subscribe

Drug Patent Expirations for Jun 18 2012

Tradename Applicant Generic Name Patent Number Patent Expiration
EPZICOM Viiv Hlthcare abacavir
sulfate; lamivudine
5,034,394*PED Jun 18, 2012
TRIZIVIR Viiv Hlthcare abacavir
sulfate; lamivudine; zidovudine
5,034,394*PED Jun
18, 2012
abacavir sulfate 5,034,394*PED Jun
18, 2012

*Drugs may be covered by multiple
patents or regulatory protections. See the DrugPatentWatch
database for complete details.

DrugPatentWatch Serves Your Competitive Intelligence

Subscribers have
access to valuable datasets, including:
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data
  • More…
See the Database
and Plan
. Contact Us with any

The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details

Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or

Continue reading